Literature DB >> 20087196

Concurrent autoimmune diseases in patients with autoimmune hepatitis.

Andreas Teufel1, Arndt Weinmann, George J Kahaly, Catherine Centner, Anja Piendl, Marcus Wörns, Ansgar W Lohse, Peter R Galle, Stephan Kanzler.   

Abstract

BACKGROUND: Although the pathomechanisms of autoimmune diseases in various organs remain unresolved, an accumulation of autoimmune diseases in individual patients has been observed. An overlap of autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) or primary sclerosing cirrhosis has been well documented. However, the overlap of autoimmune diseases other than PBC or PSC has not yet been investigated in a large cohort. GOAL: The goal of our analysis was to investigate the incidence of concurrent autoimmune diseases in patients with AIH. STUDY: We analyzed our cohort of 278 patients with AIH for concurrent autoimmune diseases.
RESULTS: A total of 111 patients (40%) were diagnosed with additional autoimmune diseases. Besides overlap syndromes for PBC and PSC, autoimmune thyroiditis was the most common concurrent disease (28 patients, 10%). Other concurrent autoimmune diseases comprised vitiligo (5 patients), rheumatoid arthritis (5 patients), Sjogren syndrome (4 patients), ulcerative colitis (4 patients), conjunctivitis (4 patients), celiac disease (3 patients), systemic lupus erythematodes (2 patients), type I diabetes (2 patients), multiple sclerosis (2 patients), polymyalgia rheumatica (2 patients), and urticaria (2 patients). One patient each was diagnosed with Crohn's disease, autoimmune gastritis, collagenous colitis, hypophysitis, and sarcoidosis. Investigating 100 patients with polyglandular syndrome and autoimmune thyroid disease for the occurrence of autoantibodies associated with AIH, we identified AIH-associated antibodies only in 1 patient.
CONCLUSIONS: Concurrent autoimmune diseases are common in patients with AIH and mirror the full range of known autoimmune diseases. Therefore, an extended diagnostic screening for accumulating autoimmune diseases, especially autoimmune thyroiditis, seems reasonable in patients with AIH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087196     DOI: 10.1097/MCG.0b013e3181c74e0d

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  45 in total

Review 1.  Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review.

Authors:  Joaquim Polido-Pereira; Ana Maria Rodrigues; Helena Canhão; Fernando Saraiva; José Alberto Pereira da Silva; João Eurico Fonseca
Journal:  Clin Rheumatol       Date:  2011-10-26       Impact factor: 2.980

Review 2.  Immune mechanisms of Concanavalin A model of autoimmune hepatitis.

Authors:  Hai-Xia Wang; Man Liu; Shun-Yan Weng; Jing-Jing Li; Chao Xie; Hong-Lin He; Wen Guan; Yun-Sheng Yuan; Jin Gao
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 3.  Autoimmune hepatitis: a review.

Authors:  Andrea A Gossard; Keith D Lindor
Journal:  J Gastroenterol       Date:  2012-04-17       Impact factor: 7.527

4.  Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers.

Authors:  Annarosa Floreani; Chiara Mangini; Anna Reig; Irene Franceschet; Nora Cazzagon; Lisa Perini; Llorenç Caballería; Silvia Cocchio; Vincenzo Baldo; Albert Parés
Journal:  Am J Gastroenterol       Date:  2016-10-25       Impact factor: 10.864

5.  The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases.

Authors:  Pilar Brito-Zerón; Nihan Acar-Denizli; Antoni Sisó-Almirall; Xavier Bosch; Fernanda Hernández; Sergi Vilanova; Mireia Villalta; Belchin Kostov; Marina Paradela; Marcelo Sanchez; José Ramírez; Africa Muxí; Antonio Berruezo; Celeste Galceran-Chaves; Antoni Xaubet; Carles Agustí; Jacobo Sellarés; Manuel Ramos-Casals
Journal:  Lung       Date:  2017-12-11       Impact factor: 2.584

6.  MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis.

Authors:  Tomohiro Katsumi; Masashi Ninomiya; Taketo Nishina; Kei Mizuno; Kyoko Tomita; Hiroaki Haga; Kazuo Okumoto; Takafumi Saito; Tooru Shimosegawa; Yoshiyuki Ueno
Journal:  Lab Invest       Date:  2016-09-26       Impact factor: 5.662

Review 7.  Extrahepatic autoimmune conditions associated with primary biliary cirrhosis.

Authors:  Annarosa Floreani; Irene Franceschet; Nora Cazzagon; Alice Spinazzè; Alessandra Buja; Patrizia Furlan; Vincenzo Baldo; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

8.  Autoimmune Hepatitis With Concomitant Pernicious Anemia: A Rare Association.

Authors:  Amir Riaz; Sikandar Khan; Rafael Miret; Pablo Bejarano; Asad Ur Rahman
Journal:  Cureus       Date:  2021-05-15

Review 9.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

Review 10.  Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.

Authors:  Renato Tozzoli; Maria Concetta Sorrentino; Nicola Bizzaro
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.